Press Releases Year All202420232022 11/30/22 Kiniksa Pharmaceuticals to Present at Bank of America Securities 2022 Biotech SMID Cap Conference 11/23/22 Kiniksa Pharmaceuticals to Present at Evercore ISI 5th Annual HealthCONx Conference 11/01/22 Kiniksa Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update 10/31/22 Kiniksa Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 1, 2022 09/12/22 Kiniksa Pharmaceuticals Announces Closing of Global License Agreement with Genentech for Vixarelimab 08/03/22 Kiniksa Pharmaceuticals to Present at 2022 Wedbush PacGrow Healthcare Conference 08/03/22 Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update 08/03/22 Kiniksa Pharmaceuticals Announces Global License Agreement with Genentech for Vixarelimab 08/02/22 Kiniksa Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 3, 2022 05/03/22 Kiniksa Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update 05/02/22 Kiniksa Pharmaceuticals to Report First Quarter 2022 Financial Results on May 3, 2022 02/22/22 Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update 02/22/22 Kiniksa Pharmaceuticals and Huadong Medicine Announce Strategic Collaboration 02/18/22 Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2021 Financial Results on February 22, 2022 01/10/22 Kiniksa Provides Corporate Update and Outlines Anticipated 2022 Milestones 01/03/22 Kiniksa Pharmaceuticals to Present at 40th Annual J.P. Morgan Healthcare Conference Print Page RSS Email Alerts Search
Year All202420232022 11/30/22 Kiniksa Pharmaceuticals to Present at Bank of America Securities 2022 Biotech SMID Cap Conference 11/23/22 Kiniksa Pharmaceuticals to Present at Evercore ISI 5th Annual HealthCONx Conference 11/01/22 Kiniksa Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update 10/31/22 Kiniksa Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 1, 2022 09/12/22 Kiniksa Pharmaceuticals Announces Closing of Global License Agreement with Genentech for Vixarelimab 08/03/22 Kiniksa Pharmaceuticals to Present at 2022 Wedbush PacGrow Healthcare Conference 08/03/22 Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update 08/03/22 Kiniksa Pharmaceuticals Announces Global License Agreement with Genentech for Vixarelimab 08/02/22 Kiniksa Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 3, 2022 05/03/22 Kiniksa Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update 05/02/22 Kiniksa Pharmaceuticals to Report First Quarter 2022 Financial Results on May 3, 2022 02/22/22 Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update 02/22/22 Kiniksa Pharmaceuticals and Huadong Medicine Announce Strategic Collaboration 02/18/22 Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2021 Financial Results on February 22, 2022 01/10/22 Kiniksa Provides Corporate Update and Outlines Anticipated 2022 Milestones 01/03/22 Kiniksa Pharmaceuticals to Present at 40th Annual J.P. Morgan Healthcare Conference